Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Axogen Inc (AXGN)

Axogen Inc (AXGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Axogen Inc 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615 USA

www.axogeninc.com Employees: 428 P: 386-462-6800 F: 386-462-6801

Description:

AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States.

Key Statistics

Overview:

Market Capitalization, $K 642,901
Enterprise Value, $K 652,471
Shares Outstanding, K 43,705
Annual Sales, $ 159,010 K
Annual Net Income, $ -21,720 K
Last Quarter Sales, $ 47,910 K
Last Quarter Net Income, $ -1,920 K
EBIT, $ -12,210 K
EBITDA, $ -5,770 K
60-Month Beta 1.13
% of Insider Shareholders 7.00%
% of Institutional Shareholders 80.29%
Float, K 40,646
% Float 93.00%
Short Volume Ratio 0.32

Growth:

1-Year Return 245.71%
3-Year Return 8.00%
5-Year Return 18.72%
5-Year Revenue Growth 89.43%
5-Year Earnings Growth 5.56%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.05 on 08/08/24
Next Earnings Date 11/05/24
Earnings Per Share ttm -0.38
EPS Growth vs. Prev Qtr 73.33%
EPS Growth vs. Prev Year 75.00%
Annual Dividend Yield 0.00%
Most Recent Dividend 1.000 on 01/27/10
Dividend Payable Date 02/12/10
Dividend Payout Ratio 0.00%

AXGN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -17.30%
Return-on-Assets % -8.63%
Profit Margin % -13.66%
Debt/Equity 0.49
Price/Sales 4.05
Price/Cash Flow N/A
Price/Book 6.21
Book Value/Share 2.19
Interest Coverage -6.65

AXGN Dividends

Date Value
01/27/10 $1.0000
02/23/05 $0.0600
07/10/92 $0.0460
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar